• Sr. Scientist

    Job Locations US-Princeton
    Posted Date 4 weeks ago(7/24/2018 3:44 PM)
    # of Openings
  • Overview

    Candidate will be responsible for the for development, execution, interpretation, and trouble-shooting of molecular biology and microbiology-based laboratory work and experiments in support of advancing our Listeria based immunotherapies.  Candidate should be prepared to develop and follow established protocols, identify and incorporate improved methods, analyze data, and keep meticulous notes. Candidate should be able to bring new methodologies to the lab and be able to train/manage others.  


    Design and perform molecular biology and microbiology-based experiments.  Execute routine laboratory work to support the advancement of our Listeria based immunotherapies.  Maintain proper research records as well as data entry/compilation.



    Reagent preparation, identifying and ordering proper supplies.




    Minimum Requirements:

    • 6+ years’ experience in a molecular biology/microbiology laboratory setting (or less, dependent upon degree)
    • Expertise with molecular biology techniques, gene editing, and cloning
    • Experience with developing and executing protocols and applying fundamental knowledge of molecular and micro-biology principles for troubleshooting
    • Ability to work independently as well as coordinate effectively within a team environment
    • Competency with routine laboratory techniques and principles, including biosafety requirements, PCR, gel electrophoresis, etc.
    • Experience working with bacterial culture, DNA, and proteins. Experience working with gram positive bacteria a plus.
    • Working knowledge of common computational tools for routine molecular biology data analysis and manipulation, including DNA/protein sequence analysis and alignment, vector design, and primer design.



    Minimum BS in molecular biology or related field. Preferred MS/PhD in molecular biology or related field.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed